Second Sight Medical Products Inc (EYES.OQ)
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|49||2015||Chairman of the Board|
|54||2015||President, Chief Executive Officer, Director|
|2017||Vice President, General Manager|
|45||2017||Vice President - Clinical Affairs|
|53||2016||Commercial Vice President, U.S. and Canada|
- BRIEF-SECOND SIGHT RECEIVES FDA EXPEDITED ACCESS PATHWAY DESIGNATION FOR ORION SYSTEM
- BRIEF-Second Sight Medical Products reports Q3 loss per share $0.12
- BRIEF-Second Sight receives FDA approval to begin first Orion human clinical study
- BRIEF-Second Sight Medical Products files for mixed shelf of upto $100 mln
- BRIEF-Second sight receives German approval to begin study to implant and evaluate Argus II in better-sighted retinitis pigmentosa patients